Tobacco and Public Health - TCSC Indonesia

164
BEHAVIORAL PHARMACOLOGY OF NICOTINE REINFORCEMENT
Lynch, W. J. and Carroll, M. E. (1999). Regulation of intravenously self-administered nicotine in rats.
Exp Clin Psychopharmacol, 7, 198–207.
Martin, T. J., Suchocki, J., May, E. L., and Martin, B. R. (1990). Pharmacological evaluation of the
antagonism of nicotine’s central effects by mecamylamine and pempidine. J Pharmacol Exp Ther,
254, 45–51.
Meltzer, L. T. and Rosecrans, J. A. (1981). Investigations on the CNS sites of action of the discriminative
stimulus effects of arecoline and nicotine. Pharmacol, Biochem and Behav, 15, 21–6.
Miller, D. K., Wilkins, L. H., Bardo, M. T., Crooks, P. A., and Dwoskin, L. P. (2001). Once weekly
administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic
receptor-mediated mechanism. Psychopharmacol, 156, 469–76.
Miyata, H., Ando, K., and Yanagita, T. (2002). Brain regions mediating the discriminative stimulus
effects of nicotine in rats.Ann NY Acad Sci, 965, 354–63.
Morrison, C. F. and Lee, P. N. (1967). A comparison of the effects of nicotine and physostigmine on a
measure of activity in the rat. Psychopharmacologia, 13, 210–21
O’Brien, C. P. (1996). Drug addiction and drug abuse. In: JG Hardman, AG Gilman, and LE Limbird,
ed. Goodman and Gilmans’s The Pharmacologic Basis of Therapeutics,New York:McGraw Hill,
pp. 557–77.
Panagis, G., Kastellakis, A., Spyraki, C., and Nomikos, G. (2000). Effects of methyllycaconitine
(MLA), an α7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of
brain stimulation reward. Psychopharmacol, 149, 388–96.
Parker, L. A. (1992). Place conditioning in a three- or four-choice apparatus: role of stimulus novelty
in drug-induced place conditioning. Behav Neurosci, 106, 294–306.
Perkins, K. A., Grobe, J. E., Epstein, L. H., Caggiula, A. C., Stiller, R. L., and Jacob, R. G. (1993).
Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav, 45,
375–81.
Perkins, K. A., DiMarco, A., Grobe, J. E., and Fonte, C. (1994). Nicotine discrimination in male and
female smokers. Psychopharmacol, 116, 407–13.
Perkins, K. A., Sanders, M., D’Amico, D., and Wilson, A. (1997). Nicotine discrimination and
self-administration in humans as a function of smoking status. Psychopharmacol, 131, 361–70.
Perkins, K. A. and Stitzer, M. (1998). Behavioral pharmacology of nicotine. In: Tarter R,
Ammerman PT, Ott P, ed. Handbook of substance abuse: Neurobehavioral Pharmacology.
New York: Plenum Press, pp. 299–317.
Perkins KA. (1999a). Nicotine self-administration. Nicotine Tob Res, 1,S133–S137.
Perkins, K. A., Sanders, M., Fonte, C., Wilson, A. S., White, W., Stiller, R., et al. (1999b). Effects of
central and peripheral nicotine blockade on human nicotine discrimination. Psychopharmacol,
142, 158–64.
Picciotto, M. R. and Corrigall, W. A. (2002). Neuronal systems underlying behaviors related to
nicotine addiction: Neural circuits and molecular genetics. J Neurosci, 22, 3338–41.
Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., et al. (1998).
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of
nicotine. Nature, 391, 173–7.
Pierce, R. C. and Kalivas, P. W. (1997). A circuitry model for the expression of behavioral sensitization
to amphetamine-like psychostimulants. Brain Res Rev, 25, 192–216.
Preston, K. L. and Bigelow, G. E. (1992). Subjective and discriminative effects of drugs. Behav
Pharmacol, 2, 293–313.
Rasmussen, T. and Swedberg, M. D. B. (1998). Reinforcing effects of nicotinic compounds:
intravenous self-administration in drug-naive mice. Pharmacol Biochem Beh, 60, 567–73.